Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2.625
Zitationen
11
Autoren
2003
Jahr
Abstract
As compared with radical cystectomy alone, the use of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin followed by radical cystectomy increases the likelihood of eliminating residual cancer in the cystectomy specimen and is associated with improved survival among patients with locally advanced bladder cancer.
Ähnliche Arbeiten
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
2018 · 5.385 Zit.
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
2016 · 3.695 Zit.
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 · 3.521 Zit.
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 · 3.453 Zit.
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 · 3.364 Zit.
Autoren
Institutionen
- The University of Texas MD Anderson Cancer Center(US)
- Cedars-Sinai Medical Center(US)
- SWOG Cancer Research Network(US)
- Cancer Research And Biostatistics(US)
- University of Chicago(US)
- Cancer Research Center(US)
- University of Pittsburgh(US)
- The University of Texas Health Science Center at San Antonio(US)
- University of Southern California(US)
- University of Colorado Denver(US)